|
|
Line 31: |
Line 31: |
| ==Downs Syndrome== | | ==Downs Syndrome== |
| ==Endurance / Exercise / Athletic Performance== | | ==Endurance / Exercise / Athletic Performance== |
| | |
| | ===2006 [https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/expphysiol.2006.033373 Effect of transdermal nicotine administration on exercise endurance in men]=== |
| | *Nicotine improved exercise endurance by 17 ± 7%, and in the absence of any effect on the usual peripheral markers, such as ventilation, heart rate and blood metabolites, we conclude that nicotine prolongs endurance by a central mechanism that may involve nicotinic receptor activation and/or altered activity of dopaminergic pathways. |
| | *[https://physoc.onlinelibrary.wiley.com/doi/pdf/10.1113/expphysiol.2006.033373 PDF Version] |
| | *Mündel, T. and Jones, D.A. (2006), Effect of transdermal nicotine administration on exercise endurance in men. Experimental Physiology, 91: 705-713. doi: 10.1113/expphysiol.2006.033373 |
| | |
| ==HIV/AIDS== | | ==HIV/AIDS== |
| ==Mental Health - Anxiety== | | ==Mental Health - Anxiety== |